HES 130-0.4: Clinical Trials

49 trials of HES 130-0.4, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 completed, 7 unknown, 4 terminated, 1 not yet recruiting. 19 Not applicable, 16 Phase 4, 8 Phase 3, 3 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable19Completed 14, Terminated 2, Unknown 2, Withdrawn 1
Phase 416Completed 10, Unknown 4, Not yet recruiting 1, Terminated 1
Phase 38Completed 7, Terminated 1
Phase 23Completed 3
Early Phase 11Unknown 1

Follow HES 130-0.4: new trials by email Literature Review of HES 130-0.4 trials Research Report on HES 130-0.4

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing Fluid Resuscitation in Adults With Major Burns: A Randomized Trial of Burn Navigator™ Versus Parkland Formula
Burn Navigator, Resuscitation (Voluven) - Resuscitation, Burn
Phase 4Not yet recruitingAlnas Hospital622026-01-012025-12-29
Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid Therapy
exposure to Hydroxyethyl Starch (HES) Voluven® or Volulyte® 130/0.4 - Meningioma of Brain, Meningioma Surgery
CompletedChiang Mai University3002025-03-012026-03-17
Cardiac Output in Preeclamptic
1000 mL of ringer's acetate solution, 250 mL 6% hydroxyethyl starch (Voluven) then 500 mL of ringer's acetate solution then 250 mL of 6% hydroxyethyl starch (Voluven) - Echocardiography
Not applicableCompletedMansoura University342022-08-172026-02-17
The Potential Therapeutic Role of Hydroxyethyl Starch and Hydrocortisone in Acute Aluminum Phosphide Poisoning
Hydroxyethyl Starch 130-0.4 60 MG/ML [Voluven], Hydrocortisone, Placebo - Potential Therapeutic Role
Not applicableCompletedTanta University602020-07-152024-05-01
Different Preloads for Prevention of Hypotension in Patients Undergoing Elective CS Under Intrathecal Anesthesia
Ringer, Voluven - Hypotension Drug-Induced
Early Phase 1UnknownAssiut University602018-03-012018-03-15
Fluid Optimization With Crystalloids and Colloids in Neurosurgery
Sterofundin (Bolus of crystalloids), Voluven (Bolus of colloids) - Postoperative Complications
Not applicableCompletedUniversity Medical Centre Ljubljana802017-01-012021-09-16
Priming of Cardiopulmonary Bypass With Hydroxyethyl Starch 130/0.4 or Sodium Chloride 0.9% : Pilot Study in Adult Elective Conventional Cardiac Surgery
Non balanced Hydroxyethyl starch 130/0.4 (Voluven®, Fresenius), Sodium Chloride 0.9% (Fresenius) - Extracorporeal Circulation, Cardiac Surgery
Phase 3CompletedHospices Civils de Lyon302016-12-062025-08-06
Colloid Pre-Loading on D-Dimer During Cesarean Section Under Spinal Anesthesia
hydroxyethyl starch (6% 130/0.4), Hyperbaric bupivacaine, Morphine - Coagulation Defect; Bleeding
Phase 2CompletedAssiut University602016-01-012016-11-08
Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery
6% hydroxyethyl starch - Cardiac Surgical Procedures
CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's20002015-05-012018-11-06
Colloid Preload Versus Colloid Coload During Cesarean Deliveries
hydroxyethyl starch (% 6 HES 130/0.4) (Voluven®), hydroxyethyl starch (%6 HES 130/0.4) (Voluven®) - Anesthesia; Adverse Effect, Spinal and Epidural, Hypotension
Phase 4UnknownSifa University2002015-03-012015-11-17
Use of 6% Hydroxyethylstarch (130/0.4) in Cardiac Surgical Patients
human albumin 5%, HES 130/0.4 (Voluven) - Postoperative Kidney Injury
Phase 3CompletedThe Cleveland Clinic1492015-03-012023-02-14
Comparison of Stroke Volume Variation-guided Normovolemic and Restrictive Fluid Management During Craniotomy: a Randomized Controlled Trial
Intravenous colloid bolus with Voluven - Supratentorial Neoplasms, Brain Tumor, Primary
Not applicableUnknownNational Taiwan University Hospital802014-04-012014-12-03
Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients
Phenylephrine, Epinephrine, Albumin - Intracranial Aneurysm, Brain Edema
Not applicableCompletedNYU Langone Health662014-03-012019-08-28
Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%
prime crystalloid, Human Albumin, Voluven - Coronary Artery Disease, Aortic Valve Disease
Not applicableWithdrawnUniversity of Saskatchewan2013-11-012019-05-03
Colloids in Pediatric Cardiac Surgery: Comparison Between a Balanced and a Non-balanced Colloid
Hydroxyethyl starch 130/0.4 in an isotonic electrolyte solution, Hydroxyethyl starch 130/0.4 in 0.9% sodium chloride - Cardiac Surgery, Cardiopulmonary Bypass
Phase 3CompletedQueen Fabiola Children's University Hospital882013-02-152020-11-09
Stroke Volume Variation and Pulse Pressure Variation as Predictors of Fluid Responsiveness During Kidney Transplantation
Fluid loading - Kidney Transplantation
Not applicableCompletedSamsung Medical Center422012-12-012015-06-02
Pulse Pressure Variation for Prediction of Fluid Responsiveness in Coronary Artery Disease Patients With Diastolic Dysfunction
Fluid loading (Voluven) - Fluid Responsiveness Predictability
Not applicableCompletedYonsei University662012-01-012014-02-19
Hydroxyethyl Starch and Renal Function After Radical Prostatectomy
Voluven (Hydroxyethyl starch 130/0,4), Sodium Chloride 9 mg/ml - Prostate Cancer
Phase 4CompletedRegional Hospital Holstebro402012-01-012013-09-17
Rotational Thromboelstometry (ROTEM) change_colloid_total Hip Replacement Arthroplasty
Pentaspan, voluven, volulyte - Avascular Necrosis of Hip, Total Hip Replacement Arthroplasty
Not applicableCompletedSeoul National University Bundang Hospital752012-01-012014-01-28
Hydroxyethyl Starch and Renal Function After Hip Replacement Surgery
Voluven (Hydroxyethyl starch 130/0,4), Sodium Chloride 9 mg/ml - Osteoarthritis
Phase 4CompletedRegional Hospital Holstebro422012-01-012013-05-29

Showing 20 of 49. Sign in to see all of them.

Conditions studied

Hypotension (7)  ·  Ischemia (3)  ·  Postoperative Complications (3)  ·  Sepsis (3)  ·  Coronary Artery Disease (2)  ·  Hemorrhage (2)  ·  Shock, Septic (2)  ·  Angina Pectoris (1)  ·  Angina, Unstable (1)  ·  Aortic Valve Disease (1)  ·  Brain Edema (1)  ·  Brain Neoplasms (1)  ·  Burns (1)  ·  Coronary Disease (1)  ·  Critical Illness (1)

Sponsors

Fresenius Kabi (4)  ·  Regional Hospital Holstebro (3)  ·  Sangart (3)  ·  Assiut University (2)  ·  Hospices Civils de Lyon (2)  ·  Seoul National University Hospital (2)  ·  The Cleveland Clinic (2)  ·  Alnas Hospital (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Biopure Corporation (1)  ·  Chiang Mai University (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Innogene Kalbiotech Pte. Ltd (1)  ·  K. C. Rasmussen (1)  ·  Karolinska Institutet (1)

Countries

South Korea (6)  ·  Sweden (6)  ·  Belgium (5)  ·  Denmark (5)  ·  Egypt (5)  ·  France (4)  ·  Austria (3)  ·  Netherlands (3)  ·  United States (3)  ·  Canada (2)  ·  Czechia (2)  ·  Germany (2)  ·  Poland (2)  ·  Argentina (1)  ·  Brazil (1)

Top investigators

Anne Sophie P. Kancir, MD PhD (3)  ·  Andra Duncan, M.D. (1)  ·  Andrea Kurz, MD (1)  ·  Arnaldo Dubin, MD (1)  ·  Aysun Afife Kar, MD (1)  ·  Bertrand Guidet, Prof., MD (1)  ·  Christian Loubert, MD, FRCPC (1)  ·  Christina I. Olofsson, MD, PhD (1)  ·  Chun-Yu Wu, MD (1)  ·  Cindy E Boom, PhD, MD (1)  ·  Erzsebet Bartha, M.D (1)  ·  Eva M Base, MD (1)  ·  Frederic Mercier, Professor (1)  ·  Gaab Soo Kim, M.D, Ph.D. (1)  ·  Hans Gombotz, Professor (1)

Results publications

PMID 11273919, PMID 11810123, PMID 14750917, PMID 15758080, PMID 16127110, PMID 18633018, PMID 19608488, PMID 20813485, PMID 21317165, PMID 21455059, PMID 21924634, PMID 22624531, PMID 23047301, PMID 23303244, PMID 23718743, PMID 23837606, PMID 24100337, PMID 24570753, PMID 24970272, PMID 25572383, PMID 25627076, PMID 26261748, PMID 26475802, PMID 26635088, PMID 26994228, PMID 27413488, PMID 28981592, PMID 30411246, PMID 31138465, PMID 32072617, PMID 32619039, PMID 32753064, PMID 33744114, PMID 33957864, PMID 33966019, PMID 34127830, PMID 34406128, PMID 35677840, PMID 35710188, PMID 35884768

NIH funding

2009 (1)